Refractory Post‐Allogeneic Stem Cell Transplant Pure Red Cell Aplasia in Remission After Treatment With Daratumumab

American Journal of Hematology - United States
doi 10.1002/ajh.25515
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Pure Red Cell Aplasia After Allogeneic Stem Cell Transplantation With Reduced Conditioning

Bone Marrow Transplantation
TransplantationHematology
2000English

Allogeneic Stem Cell Transplantation for Acquired Pure Red Cell Aplasia

American Journal of Hematology
Hematology
2019English

Successful Treatment of Isohemagglutinin-Mediated Pure Red Cell Aplasia After ABO-mismatched Allogeneic Hematopoietic Cell Transplant Using Bortezomib

Bone Marrow Transplantation
TransplantationHematology
2011English

Pure Red Cell Aplasia After Kidney Transplantation

American Journal of Transplantation
TransplantationAllergyImmunologyPharmacology
2019English

A Rare Case of Thymoma With Pure Red Cell Aplasia With Initial Remission of Anaemia After Thymectomy

Journal of Evolution of Medical and Dental sciences
2013English

Emtricitabine-Induced Pure Red Cell Aplasia

Southern African Journal of HIV Medicine
Infectious Diseases
2019English

Post-Transplant Lymphoproliferative Disorder in Patients With Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Post‐allogeneic Transplant Evans Syndrome Successfully Treated With Daratumumab

British Journal of Haematology
Hematology
2019English

Post-Mortem Incidental Finding of Cytomegalovirus Oophoritis After an Allogeneic Stem Cell Transplant

Bone Marrow Transplantation
TransplantationHematology
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy